Family Members Prefer Compassionate End-of-Life Care for Cancer Patients
Results of the study in JAMA underscore the importance of advance care planning.
Outdated Metrics in the Age of Precision Medicine
Panelists discussing quality metrics in oncology were not sure payment and federal policies could keep pace with what's happening on the front lines.
Panelists Predict FFS Will Grow More Cumbersome
CMS has attempted to tailor ACOs to meet a variety of needs and levels of risk, depending on where parties are in their knowledge level of payment reform.
Bridging the Communication Gap to Overcome "Financial Toxicity"
Yousuf Zafar, MD, MHS, found that most cancer patients would like to discuss financial concerns with their doctors, but few actually do, for a variety of reasons.
Putting Big Data to Work for Better Care in Oncology
Flatiron Health seeks to use data to prevent the patient experience from being lost.
Are PBMs the Answer to Managing the High Cost in Oncology Care?
The pharmacy benefit manager may be the "new sheriff in town" in an era of rising costs.
As "Me-Too" Options Expand, Cost, Side Effects Become Considerations, McCullough Explains
Choosing a therapy with fewer side effects can increase efficacy because patients stick with it, said Stacey McCullough, PharmD, of Tennessee Oncology.
Precision Therapeutics Can Pave the Path to Curing Cancer
Immunotherapy represents the "next frontier" in cancer care, according to Joseph Alvarnas, MD, of City of Hope, who is editor-in-chief of Evidence-Based Oncology.
Becoming a More Educated e-Patient
After being diagnosed with a rare blood cancer, Jack Whelan has used his electronic connections to be more involved in his care.
Kolodziej on Precision Medicine: Standardization, Transparency Needed in Data Collection
Broad treatment guidelines may be based on relatively narrow trial data.
As Prospect of Risk for Doctors Looms, Cost Conversation Shifts in Cancer Care
Oncologists now face a cost discussion that was not part of their medical training. It's a balancing act between the big picture of understanding the burdens on the system and "the patient in front of you."
ASCO President Reviews Post-SGR Challenges for Oncologists
Keynote speaker Dr Julie Vose said the oncologist faces many administrative burdens in the transition to value-based care. Solving them is essential to spending more time with the patient.
Diagnostic Testing Is a Wild West of Unknowns, Perils
The timely panel took place just after FDA issued a report on why it feels regulatory oversight of testing is necessary.
Genetic Counselors Can Weed Out Errors, Ensure Patients Get Needed Tests, Larsen Haidle Says
A thorough family history is the foundation of precision medicine, according to the 2015 president of the National Society of Genetic Counselors.
Personalized Medicine Enters the "Postgenome Revolution"
Emanuel F. Petricoin III, PhD, said patients have much to gain from "democratization" as clinical trials move beyond academic centers.
2 Clarke Drive Cranbury, NJ 08512